Circulating microRNAs and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease

计划入组 460 人 · 首次发布于 2018 年 8 月 17 日

The Relationship of Platelet Micro-RNA Expression and Platelet Reactivity in Patients Under Clopidogrel or Ticagrelor Treatment

计划入组 175 人 · 首次发布于 2014 年 4 月 2 日

ZAZA study

计划入组 32 人

4AZA-PDE4

RAPA-113

RAPA-115

MIRZA, NATASHA

United States

Mirna Therapeutics, Inc.

United States

Razi University

Acrivon Therapeutics Appoints Renowned Oncologist Dr. Mansoor Raza Mirza as Chief Medical Officer to Lead Clinical Development

Dostarlimab Shows Superior Survival Outcomes Across Multiple Endometrial Cancer Molecular Subgroups in Phase 3 RUBY Trial

Acrivon Therapeutics to Showcase AP3 Platform and Clinical Program Updates at Upcoming R&D Event